J. Goldman & CO LP Pacira Bio Sciences, Inc. Call Options Transaction History

J. Goldman & CO LP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2024 Feb 14, 2025	BUY	$15.3 - $20.33 $2.07 Million - $2.74 Million	135,000 New	135,000 $2.54 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $2.43 Million - $3.2 Million	67,400 New	67,400 $2.7 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $1.43 Million - $1.8 Million	40,000 New	40,000 $1.52 Million
Q4 2017 Feb 14, 2018	SELL	$31.85 - $46.95 $955,500 - $1.41 Million	-30,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.7 - $39.5 $1.07 Million - $1.19 Million	30,000	30,000 $1.13 Million

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.15B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.